Global and United States Peripheral Intervention Drug-Eluting Devices Market Report & Forecast 2022-2028

Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
Market Analysis and Insights: Global and United States Peripheral Intervention Drug-Eluting Devices Market
This report focuses on global and United States Peripheral Intervention Drug-Eluting Devices market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Peripheral Intervention Drug-Eluting Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Drug-Eluting Balloons accounting for % of the Peripheral Intervention Drug-Eluting Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Plain Old Balloon Angioplasty (POBA) was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Peripheral Intervention Drug-Eluting Devices market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Peripheral Intervention Drug-Eluting Devices Scope and Market Size
Peripheral Intervention Drug-Eluting Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Peripheral Intervention Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Peripheral Intervention Drug-Eluting Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
Drug-Eluting Balloons
Drug-Eluting Stents

Segment by Application
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation